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Abstract
Background: In proteomics experiments, database-search programs are the method of choice for
protein identification from tandem mass spectra. As amino acid sequence databases grow however,
computing resources required for these programs have become prohibitive, particularly in
searches for modified proteins. Recently, methods to limit the number of spectra to be searched
based on spectral quality have been proposed by different research groups, but rankings of spectral
quality have thus far been based on arbitrary cut-off values. In this work, we develop a more readily
interpretable spectral quality statistic by providing probability values for the likelihood that spectra
will be identifiable.
Results: We describe an application, msmsEval, that builds on previous work by statistically
modeling the spectral quality discriminant function using a Gaussian mixture model. This allows a
researcher to filter spectra based on the probability that a spectrum will ultimately be identified by
database searching. We show that spectra that are predicted by msmsEval to be of high quality, yet
remain unidentified in standard database searches, are candidates for more intensive search
strategies. Using a well studied public dataset we also show that a high proportion (83.9%) of the
spectra predicted by msmsEval to be of high quality but that elude standard search strategies, are
in fact interpretable.
Conclusion: msmsEval will be useful for high-throughput proteomics projects and is freely
available for download from http://proteomics.ucd.ie/msmseval. Supports Windows, Mac OS X and
Linux/Unix operating systems.
Background
The identification of proteins by tandem mass spectrome-
try (MS/MS) is an important step in many proteomics
studies [1]. The introduction of orthogonal peptide sepa-
ration techniques coupled to the mass spectrometer, such
as multidimensional protein identification technology
(MudPIT) [2] and combined fractional diagonal chroma-
tography (COFRADIC) [3], has significantly increased the
potential throughput of tandem mass spectrometry exper-
iments, enabling the identification of 100s or 1000s of
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been fully realized because the vast amount of primary
data generates computational burdens, notably time-con-
suming and processor-intensive tandem mass spectra
interpretation. The most widely-used interpretation pro-
grams, such as SEQUEST [4], X!Tandem [5] and Mascot
[6], use amino acid sequence databases that are expanding
in size daily. Recently, heuristic programs such as X!Tan-
dem [5] and PFSM [7] have been reported to reduce search
times by 80–90%. Even so, an emerging goal for the biol-
ogist is to identify the post-translational modifications or
mutations in proteins that are often the basis for disease
states [1,8]. Search time would grow exponentially if the
search space is increased to account for all possible modi-
fications.
One approach for reducing search time is to remove MS/
MS spectra that are unlikely to be identified. Currently, up
to 90% of tandem mass spectra recorded in a typical mul-
tiple dimensional chromatography (LCn) MS/MS run can-
not be identified by database search methods. There are
multiple reasons for this, including the presence of non-
peptide signals derived from chemical or electronic
sources. Of the spectra that do represent peptide signals,
many remain unidentified because the spectra are of poor
quality, or because the cognate proteins contain amino
acid polymorphisms, post-translational modifications, or
splice variants that are not anticipated by the search pro-
grams. Other proteins are simply not present in the
sequence databases.
Recently, attempts have been made to infer spectral qual-
ity by combining a finite number of spectral features into
a score that discriminates low from high quality spectra
[9-14]. In general, the methods rely on combining a finite
number of spectral features into a score that is a measure
of spectral quality and discriminates high quality from
low quality spectra. For discriminant function definition,
a training dataset partitioned by cross-correlation score
(e.g. [10]) or containing pre-annotated spectra (e.g. [8]) is
used. Early efforts focused on defining general discrimi-
nant function primarily used for the rejection of low qual-
ity spectra prior to database searching [11]. More recently,
Nesvizhskii and coworkers (2006) described an approach
where a new discriminant function is defined for each
dataset for finding high quality spectra that have not been
annotated by a first pass database search [12]. Bern and
coworkers (2004) also prioritized spectra for intensive
interpretation efforts and used regression analysis to gen-
erate a continuous score measuring the number of b- and
y-ions in a spectrum [9].
Here, we present a statistical model that assesses the qual-
ity of tandem mass spectrum from any LCn/MS/MS run
(or collection of MS/MS spectra) prior to database search-
ing. In previous work, authors have suggested arbitrary
cut-off scores that may be used as a guideline to determine
whether a spectrum is a likely candidate for further analy-
sis, but such an approach is undesirable because average
spectral quality typically varies with different samples,
experiment formats, instruments and laboratories. Fur-
thermore, even if the discriminant function has been
adapted for a particular dataset, arbitrary cut-off scores are
difficult to interpret in relation to their ability to reject low
quality spectra. We therefore build on previous efforts and
present a freely-available program that assigns the proba-
bility that a tandem mass spectrum will yield a positive
peptide identification. We show that our assigned proba-
bility is indeed a good estimate of the observed value and
therefore is of practical use in a proteomics lab using dif-
ferent instrument platforms or different types of experi-
mental samples. msmsEval is useful for reducing search
processing time and for selecting high quality unidenti-




Two groups of experimental MS/MS datasets were used to
train and evaluate the spectral quality evaluation algo-
rithm.
1) The UCD dataset was generated in-house and consisted
of 142,582 MS/MS spectra from 22 LCn/MS/MS runs,
including commercial standard proteins, cultured cell
extracts, and human vascular proteins, were acquired
from different samples over a 6 month period. Three dif-
ferent database search strategies were used to annotate the
dataset.
Briefly, SEQUEST [4]/PeptideProphet [15]/Protein-
Prophet [16] was used to identify spectra whose anno-
tated amino acid sequences were presented in the
UniProtKB/Swiss-Prot database (release 6.0). InsPecT [17]
was used to identify peptides based on sequence tags and
pepNovo [18]/SPIDER [19] used a combined de novo/tag
approach (see experimental methods for details). The
three strategies represent distinct approaches to identify-
ing peptides from experimental tandem mass spectra (typ-
ically only the first method is used in most labs).
If a spectrum is matched by any of the three search meth-
ods described, these were regarded as annotated. Of the
142,582 spectra, 16,999 were annotated and therefore
classed as identifiable (see Additional file 1). The presence
of mislabeled spectra in the training data could degrade
the accuracy of prediction of the resulting classifier [20].
To minimize this, we applied a 9-fold cross-validation/k-
nearest neighbor strategy (see Additional file 2: Appendix
1).Page 2 of 11
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datasets such that the training dataset consisted of 12 runs
with 9,044 identified and 69,584 unidentified, while the
test dataset consisted of 10 runs with 7,955 identified and
55,999 unidentified.
2) ISB dataset. The second dataset was the publicly availa-
ble ISB dataset consisting of 22 LC/MS/MS runs of artifi-
cially generated protein mixture digests [21]. We used this
dataset to compare identification probabilities predicted
using our program to the identification frequencies
observed by Tsur and coworkers who used a "blind"
approach resulting in the identification of many modified
proteins [18]. This dataset consists of 39,408 MS/MS spec-
tra. Initial efforts using SEQUEST by ISB annotated 4,310
spectra, while Tsur and coworkers [18] were able to anno-
tate an additional 1,176 spectra. Note that the number of
spectra in the dataset appear to differ from those available
from the website. This is because the DTA files generated
by Keller and coworkers [21] clustered adjacent MS/MS
scans of similar parent mass. Because our algorithm eval-
uates scans individually without clustering, the spectra
annotations from ISB and Tsur and coworkers [18] were
"declustered" to generate our dataset.
Spectral features
A set of spectral features, similar to those used by previous
workers, was used to measure the quality of MS/MS spec-
tra. We applied a unique normalization procedure in an
attempt to capture specific information from b or y ions
that may be present. The intensity of peaks was initially
normalized by assigning to each peak its intensity rank
within a local segment, i, of 56 m/z for each spectrum, this
value being chosen because there normally will be no
more than one y and b ion within such a segment unless
the charge state of the precursor ion is 3 or greater. This
improves the signal-to-noise ratio for the whole spectrum
by taking advantage of the fact that b or y ions are typically
the most intense ions within any local region of a peptide
tandem mass spectrum [22]. We tested all features in com-
bination, details are reported in Appendix 2.
In order to eliminate potential feature bias between spec-
tra generated from singly and multiply charged precur-
sors, these were distinguished using a similar algorithm
similar to that described by Hansen and co-workers [23],
and the maximum m/z value, was adjusted to the mass of
the precursor ion for spectra derived from singly charged
ions. We found no significant performance differences
when we streamed our data into +1, +2, and +3 sets, in
agreement with previous reports [9,11]. The definition of
each spectral feature can be found in the experimental
methods section.
Combining spectral features by logistic regression
The next step is to combine spectral features in order to
make predictions on their general quality. Numerous clas-
sification algorithms may be used. In general, non-linear
classifiers such as quadratic discriminant analysis (QDA)
or multi-layered artificial neural networks tend to provide
better classification than linear classifiers such as linear
discriminant analysis (LDA) if the dataset is not linearly
separable. To test whether non-linear classifiers are likely
to be advantageous in this case, the training dataset was
used to train a quadratic discriminant function and a lin-
ear discriminant function. The functions were then evalu-
ated using our UCD test dataset. In this case, no
significant difference was observed (see Additional file 2:
Appendix 2) and as result a linear classifier was chosen for
its simplicity in application and interpretation.
Logistic regression is a method that allows the discrimina-
tion between two or more groups of samples based on a
vector of given variables for each sample through a logistic
function. The basis of the method is similar to that of lin-
ear discriminant analysis (LDA) in combining spectral
features by a weighted linear function, such that,
where xi are the spectral features described previously and
ci the corresponding coefficients. However, unlike LDA,
logistic regression express D as a probability of being
"true" through the use of a logistic function, such that,
where θ is a value between 0 and 1, indicating the proba-
bility of a spectrum with value D being "true" or in our
case, being an identifiable spectrum. The principle of
maximum likelihood is applied by iteratively finding the
best estimates for coefficients ci such that the training data
best fit equation 2. Unlike LDA, the discriminant function
D is maximized by maximum likelihood, relaxing the
assumptions required to construct the model. For exam-
ple, the features do not need to be normally distributed
and the number of identifiable and unidentifiable train-
ing samples need not be similar. Further, because the
maximization of the logistic function is probability based,
the significance of features can be easily evaluated
through analysis of the t-statistic, given the standard errors
of the estimated coefficients.
We selected spectral features for the final model in an iter-
ative process, removing features that did not contribute
significantly to the final discriminant model. A logistic
regression model was computed using all features availa-
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variable to interpret their contribution to the model. It
was found that IntnRatio20% and H2ORatio did not con-
tribute significantly based on our training set (see Addi-
tional file 2: Appendix 3). These features were then
removed and the discriminant model recalculated.
Statistical modeling of the identifiable and unidentifiable 
spectra distributions
Once the features of a spectrum are combined into a dis-
criminant score, a statistical model can be used to assess
the likelihood of that spectrum being identifiable or uni-
dentifiable based on the spectra distributions of the com-
plete dataset. The first step is to build models for the
identifiable and the unidentifiable spectra.
Figure 1 shows the distribution for the identified and uni-
dentified UCD test spectra tallied within bins of width
0.25 according to the discriminant score, D. It is evident
that identifiable spectra approximately follow a Gaussian
distribution (dotted line), while the distribution of the
unidentifiable spectra has a slight positive skew (longer
right-tail), probably resulting from high quality but uni-
dentifiable spectra (i.e. misclassified) (see e.g. [11,12]).
Thus, it would be reasonable to disregard the skewness
and also model the unidentifiable spectra using a Gaus-
sian distribution. Based on Gaussian distributions, the
probability that a spectrum has a discriminant score, D,
given that it is identifiable can be computed as,
where + corresponds to "identifiable spectrum", µ+ and σ+
are the mean and standard deviation of the distribution
respectively. The conditional probability p(D|-), where –
corresponds to "unidentifiable spectrum" is similarly
computed using the mean and standard deviation of the
unidentifiable spectra distribution.
Since the estimated distributions will not match the
observed distributions for each new dataset, the problem
may now be treated as learning a mixture of two Gaussian
distributions. An efficient algorithm that is commonly
applied to perform unsupervised learning of mixture
models is the expectation-maximization (EM) algorithm
[24,25]. This algorithm calculates the maximum likeli-
hood estimation for fitting a given model. The Peptide-
Prophet [15] software for predicting likelihoods for a
correctly annotated MS/MS spectrum uses a similar
approach. In this case, the EM algorithm is initialized
using the prior probabilities and parameters of the distri-
butions estimated from our combined test dataset (Figure
1). The EM algorithm optimizes these by iteratively calcu-
lating the expected probability assignment, p(+|D) for
each spectrum, using equation 3 and Bayes' Law
In turn the EM algorithm uses the expected probability
estimated to optimize the prior probability, p(+) and
parameters σ and µ for the + and – distributions, such that
where n is the number of spectra in the dataset.
The prior probability for the unidentifiable spectra is (1-
p(+)). The distribution parameters are calculated similarly
but use (1-p(+|Di)) as the likelihood estimate for a spec-
trum being unidentifiable.
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Modeling identifiable mass spectra using discriminant scoring of sp ctral f a uresFigure 1
Modeling identifiable mass spectra using discriminant 
scoring of spectral features. The distributions of identifia-
ble and unidentifiable spectra in the UCD test dataset were 
plotted. The number of spectra is calculated with spectra 
placed in bins of 0.25 for the discriminant score. The solid 
lines show the actual distributions of spectra while the dot-
ted lines indicate the estimated Gaussian distributions used 
to model each distribution.Page 4 of 11
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nificant changes to the estimated parameters between iter-
ations. Supplementary Figure 2 (see Additional file 3)
show examples of the algorithm used to fit datasets with
different spectra distributions. In general the predicted
identifiable and unidentifiable spectra distributions
match the observed well, especially for the UCD dataset.
For the ISB example, the unidentified spectra distribution
is less well modeled; this may be a consequence of the
smaller number of spectra available, or may reflect the
need to include an additional distribution for effective
modeling. Nevertheless, the predicted model still pro-
vides a reasonable estimate and importantly, the identifi-
able distribution is modeled well which is of principal
importance for finding high quality spectra.
Illustrative examples
Removal of low quality unidentifiable spectra
We demonstrate the use of the assigned probabilities as a
method for removing spectra that are unlikely to be iden-
tifiable from the test datasets. Runs of the UCD test data-
set and ISB dataset were each analyzed and modeled
separately using msmsEval. To demonstrate the accuracy
of the algorithm, the estimated fraction of identifiable
spectra removed at various points (the estimated fraction
is calculated from the corresponding percentile values
from the identifiable spectra Gaussian plot) is plotted
against the actual observed fractions (Figure 2A&B).
For the UCD test dataset (Figure 2A), it can be seen that
observed and predicted fractions for the identified spectra
show reasonable agreement. The error bars indicate that
there is some variance in the prediction between the data-
sets, this is likely due to the diversity of runs within the
test dataset. As expected, the variance between runs from
the ISB dataset is lower than for the UCD dataset (Figure
2B). This is because runs within the ISB dataset contain a
low number of proteins, are of similar constituents and
was presumably acquired during a single study. In the
UCD case the data comprised of diverse real world exam-
ples from an active proteomics lab. It is also observed that
the predicted fraction slightly underestimates the
observed fraction, probably because spectra annotated by
SEQUEST were not filtered by PeptideProphet (which was
used to annotate the ISB dataset) and as a result there are
a higher number of low quality identified spectra. Never-
theless, in both cases, the fraction of unidentified spectra
removed is significantly higher than identified for frac-
tions less than one.
Figure 2C shows the average fraction of unidentifiable
spectra removed in relation to identified. For both data-
sets the shape of the receiver-operator-curve are similar. In
general, the greater the number of unidentified spectra
removed, greater the number of identifiable spectra also
removed. For practical purposes in a proteomics labora-
tory, a user will want to maximize the removal of uniden-
tifiable spectra without significant lost of identifiable
spectra. From Figure 2C, it can be observed that the
removal of 50% of unidentifiable spectra, resulting in a
two-fold decrease in computer search time, will remove
only 1–2% of identifiable spectra. This is consistent with
other reports.
Guide for finding modified spectra
To demonstrate that the model is reliable in predicting the
probability that a spectrum is identifiable, p(+|D), the
estimated probability is plotted against the observed
probability for the ISB dataset (Figure 3A). Spectra were
sorted based on the predicted p(+|D), and for bins of 100
spectra, the average p(+|D) was calculated and plotted
against the fraction of observed identifiable spectra in
those same bin. Figure 3A shows that when p(+|D) is plot-
ted against spectra that were only annotated using
SEQUEST (crosses), the observed probabilities underesti-
mate the predicted probabilities (e.g. only 60% of spectra
with predicted p(+|D) = 0.9 are being identified when one
would expect 90%). However with the addition of the
spectra representing mostly modified peptide annotated
by Tsur and coworkers (2005) [18], it can be seen that the
observed probability becomes significantly closer to the
predicted probability (diamonds).
Despite the improvement, the estimated probability still
appears to over-estimate the observed, particularly for
higher p(+|D). To investigate whether this discrepancy all
remaining unidentified spectra with p(+|D) > 0.9 (673
spectra) were further analysed as described in the experi-
mental section. Of these spectra, 212 were deemed to be
correctly annotated confirming that there were indeed
unannotated high quality spectra that were still unidenti-
fied. The newly annotated spectra belonged to one of the
following three categories (a full list with annotation is
available at the msmsEval website):
1) Two new proteins. A number of spectra were annotated
as peptides of bovine alpha-S1 and alpha-S2-casein which
are proteins not from the original set of 18 standard pro-
teins. 68 and 61 spectra were assigned to unique tryptic
fragments of one of these proteins by SEQUEST and
InsPecT respectively against a UniProt database (see
experimental section for search description) giving very
strong evidence that the annotations are correct. The
bovine beta-casein preparation from Sigma C6905 is only
> 90% pure, while alpha casein is also present in bovine
milk.
2) Further spectra of unmodified peptides of one of the 18
standard proteins were annotated. These were found byPage 5 of 11
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Removal unidentifiable spectra by msmsEvalFigure 2
Removal unidentifiable spectra by msmsEval. The predicted fraction of spectra removed for identifiable () and uniden-
tifiable (x) spectra were plotted against the observed fractions for 10 runs of the UCD test dataset (A) and 22 runs of the ISB 
test dataset (B). The estimated fraction of spectra removed is calculated by taking the respective percentiles from the identifia-
ble spectra Gaussian distributions. The diagonal thin dashed line shows expected trend for the removal of identifiable spectra if 
the estimated values match the observed values perfectly. Error bars are one standard deviation from the average of the 
respective test datasets. Receiver operator curves showing the fraction of identifiable spectra removed versus unidentifiable 
spectra removed for the UCD test dataset (solid line) and ISB dataset (dashed line) are also shown (C).
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msmsEval highlights strong candidates for modified peptide spectraFigure 3
msmsEval highlights strong candidates for modified peptide spectra. The observed p(+|D) versus predicted p(+|D) 
values for 22 runs of the ISB dataset (A) were plotted using binned sets of 100 spectra (i.e. the fraction of the 100 spectra that 
were observed to be identifiable versus the mean p(+|D)). Observed p(+|D) values calculated using SEQUEST identifications 
(x), SEQUEST and MSAlignment/InsPecT identifications (), and SEQUEST and MSAlignment/InsPecT identifications as well as 
the additional assignments described in the text (o), are indicated. A pie chart (B) shows the absolute numbers and percentages 
of spectra from the ISB dataset with predicted p(+|D) > 0.9 that were identified by SEQUEST/MSAlignment/InsPecT, those that 
were additionally identified by msmsEval, and those that remain unidentified. In total, 83.9% of spectra with p(+|D) > 0.9 were 
identified.
BMC Bioinformatics 2007, 8:51 http://www.biomedcentral.com/1471-2105/8/51increasing the tolerance for mass errors allowed in our
searches.
3) Spectra of modified peptides of one of the 18 standard
proteins. It is perhaps surprising that previous efforts by
Tsur and coworkers [18] did not identify these spectra,
however this could be due to a number of factors includ-
ing the use of different parameters (e.g. maximum
number of modifications allowed) or a different version
of InsPecT. The majority of modifications observed were
multiple methionine oxidations. However, we also
observed amino acid polymorphisms. For example the
mutation of Gln-1871 into Pro in rabbit myosin heavy
chain. There is sufficient evidence that this annotation is
correct as it is observed 10 times in the InsPecT blind
search, in all cases with a p-value below 0.05. In addition,
the mutation of glutamine into proline is reasonable
given that it only requires the mutation of a single DNA
base.
Notably, the inclusion of the newly annotated spectra into
Figure 3A increases the correspondence between the pre-
dicted p(+|D) and the observed probability (circles). In
fact, 83.7% of all spectra in the ISB dataset with a pre-
dicted p(+|D) of greater than 0.9 have now been anno-
tated (Figure 3B).
Discussion
Our results and previous work show that the ability to
assess the quality of tandem mass spectra independent of
database searching can improve throughput and perform-
ance of MS-based proteomics projects. We demonstrated
the use of msmsEval on data from different real life
sources, and show that computed probabilities reflect the
observed values, and are therefore useful for removing
low quality spectra prior to database searching, and/or for
locating high quality unassigned spectra. For instance,
removing 50% of poor quality (unidentified) spectra
would result in removal of only ~2% (UCD) to ~1% (ISB)
of high quality (identifiable spectra). Notably, our algo-
rithm automatically adjusts the p(+|D) values to the slight
variations of spectral quality distributions in the different
datasets.
Ideally, the spectral quality discriminant function should
be retrained for each type of data acquired on different
instruments [12]. The EM algorithm automatically adapts
the statistical models to different discriminant functions
and will account for variations between datasets. Never-
theless, the use of a new discriminant function specific to
each dataset should provide greater accuracy, and our soft-
ware implementation, msmsEval, provides the ability to
use newly trained discriminant functions. Furthermore,
while generally the EM algorithm will converge on the
correct local minimum given a large sample size (i.e. more
than 500 spectra), it is acknowledge that skewed datasets
such as those with very few identifiable spectra will pose a
greater challenge for the EM algorithm to converge at the
correct solution. To increase the robustness of the EM
algorithm, options are available in the software to con-
strain the Gaussian mixture model parameters. Like the
discriminant function, such constrains can be altered
based on new training datasets.
While the major contribution of this work is the develop-
ment of a method to statistically model the quality distri-
bution of tandem mass spectra, we have also shown that
there are indeed significant numbers of high quality spec-
tra that remain unannotated in multidimensional LC/MS/
MS experiments and that these can be retrieved by msm-
sEval with high confidence. Using the well annotated ISB
dataset, we show that this may reflect the presence of
unknown contaminants, amino acid polymorphisms, or
post-translational modifications. Currently attempts are
being made to annotate high quality unidentified samples
from our UCD dataset. As many of the samples are from
"real life" human vascular proteins, it is anticipated that
the range of unknown proteins, posttranslational modifi-
cations and amino acid polymorphisms will be signifi-
cantly greater than those present in standard datasets such
as the ISB dataset. Efforts to annotate such spectra will
require the use of translated genome sequences in combi-
nation with blind searches for unanticipated modifica-
tions. These analyses are extremely time consuming (more
than a minute per megabyte of database searched using
InsPecT in blind mode per spectrum) and the use of spec-
tra quality assessment is a major step towards enabling
such searches.
Conclusion
A probability based method of assessing the quality of
peptide tandem mass spectra has been developed by
empirically modeling the distribution of spectra within a
single or multidimensional LC/MS/MS run based on
selected spectral features. The ability to rapidly and accu-
rately estimate the quality of a tandem mass spectrum
brings significant benefits to high-throughput proteom-
ics, 1) the fraction of potentially identifiable spectra that
may be removed can be estimated when rejecting low
quality spectra, and 2) the probability that a given spec-
trum will be identifiable will allow greater selectivity
when focusing efforts toward identifying unannotated
high quality spectra.
Methods
Generation and annotation of experimental dataset
All spectra were acquired from ion trap mass spectrome-
ters with electrospray ion sources following LC, LC-LC or
MudPIT type experiments. Cysteine thiol groups were
reduced and alkylated using iodoacetamide. SubsequentlyPage 8 of 11
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tures were separated using reverse phase and cation
exchange chromatography prior to mass spectrometry
analysis as described in Cagney et al. [26]. Three different
database search strategies were used to annotate the data-
set.
a. SEQUEST/PeptideProphet/ProteinProphet. Spectra
were first searched using SEQUEST, with all multiply
charged spectra search twice as 2+ and 3+ against the
SwissProt database (UniProtKB/Swiss-Prot, Release 6.0)
Carboxymethylation of cysteines (+57) was specified as a
fixed modification while methionine oxidation (+18) was
specified as a variable modification. Subsequently, the
results were evaluated using PeptideProphet [15] and Pro-
teinProphet [16]. All spectra with a protein and peptide
probability of greater than 0.9 were deemed as correctly
identified.
b. InsPecT. Spectra were searched using the InsPecT [17],
a tag-based database search algorithm. The same amino
acid modifications were specified as for the SEQUEST
search. To determine whether a spectrum was correctly
annotated, a list of candidate proteins that are supported
by two or more unique peptides was first generated. Sub-
sequently, all spectra within the dataset that have a p-
value of < 0.05 and are annotated as a peptide of a protein
from the list of candidate proteins were deemed as cor-
rectly identified.
c. pepNovo/SPIDER. pepNovo [27] was used to infer an
amino acid sequence for each spectrum. In addition, up to
ten sequence tags of lengths 4, 5 and 6 were also gener-
ated. For each spectrum, the inferred amino acid sequence
and the sets of tags were used as input for SPIDER [19],
such that for each spectrum, four SPIDER searches, one for
each set of tag lengths and one for the full sequence, were
performed. The candidate protein with the maximal com-
bined score was temporarily assigned to each spectrum.
Subsequently, the same procedure used for InsPecT was
applied to determine whether a spectrum has been cor-
rectly annotated.
Spectral feature definition
1. NPeaks. The number of peaks in a spectrum.
2. NormTIC. Normalized total ion count, where the value
is the ratio of the total ion count of the current spectrum
to the mean total ion count of all spectra within the same
run.
3. GoodSegs. The ratio of the number of segments, i, of size
56 m/z that are likely to be occupied by a b or y ion, to the
total number of occupied and unoccupied segments such
that,
where Intn(xrank(1)) and Intn(xrank(5)) are the intensity of
the first and fifth most intense peaks (xrank(1), xrank(5))
within segment, i, respectively. Likely b or y ion occupa-
tion of a segment is assessed by comparing the most and
fifth-most intense peaks to reduce the possibility of com-
paring b and y ions that exist within the same segment, or
that represent isotope shoulder peaks. If there are fewer
than five peaks within i, then the least intense peak is
used.
4. IntnRatio1%. The ratio of peaks that have a relative
intensity of greater than 1% of total intensity
5. IntnRatio20%. The ratio of peaks that has a relative
intensity of greater than 20% of total intensity
Note that measuring the intensity ratio cut-offs (equation
3 and 4) may appear to have statistical independence
issues. However, as there is no relationship between the
number of peaks between 0–1% and 1–20% of total
intensity (data not shown; [11]), the result of equations 3
& 4 should be independent.
6. Complements. Pairs of peaks whose m/z values add
together to give the m/z of the parent. The feature is com-
puted for the most commonly observed charge states of
1+, 2+ or 3+. The charge state with the greatest feature
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For peptides with charge 2+ or more, the formula is
adjusted appropriately, i.e. for 3+, one of the fragment
ions is multiplied by 2. This implements a method similar
to 2 to 3 [28] where the aim is to estimate the charge state
of a precursor peptide by observing complementary
peaks.
7. IsoRatio. The presence of isotope peaks associated with
an inferred b or y ion by measuring the proportion of
peaks of rank 1 or 2 associated with an isotope peak, such
that,
An error margin of ± 0.3 was used for parent mass match-
ing.
8. H2ORatio. The presence of water loss peaks associated
with inferred b or y ion by measuring the proportion of
peaks ranked 1 or 2 associated with a water loss, such that,
An error margin of ± 0.3 was used for parent mass match-
ing.
9. AAdiffRatio. This feature quantifies evidence for b or y
ion pairs separated by amino acid masses by measuring
the ratio of the most intense peak within each segment, i,
that has an associated peak (not necessarily in segment i)
whose distance from the most intense peak is equivalent
to the mass of one of the amino acids ± 0.3, such that,
where M(AA) is the mass of one of the 20 amino acids.
Note that modified proteins can be included in the algo-
rithm by substituting non-standard amino acid masses
into AAdiff, for instance the mass of caboxymethyl-
cysteine.
While some of our variables (equations 2, 3, 4, 6, 7) have
bounds of 0 to 1, the remaining variables are not
bounded. However, through all our observed training and
test spectra, no spurious variation were observed and the
distribution were smooth and continuous (data not
shown) and from our knowledge of the nature of tandem
mass spectra in relation to our features, it is a reasonable
assumption that this observation may be generalized.
Further analysis of high quality unidentified spectra
The existence of high quality unannotated spectra within
the ISB dataset as predicted by our method prompted fur-
ther investigation. Three different searches were per-
formed as described below:
1) SEQUEST was performed against the SwissProt data-
base (UniProtKB/Swiss-Prot, Release 6.0). The parent
mass tolerance was set at +/- 5. Furthermore, methionine
oxidation and cysteine caboxylmethylation were specified
as optional.
2) InsPecT was performed using equivalent settings to the
above for the SEQUEST search.
InsPecT was performed in blind search mode (i.e.
MSAlignment) allowing a maximum of two unanticipated
modifications up to a maximum mass of 300 Da. As
InsPecT in blind search mode is very time consuming, the
search was performed using a small database containing
only the known 18 standard proteins [21], common con-
taminants (e.g. trypsin and keratin) and an additional 100
proteins randomly chosen from the human database to
act as distracter proteins.
Availability and requirements
The algorithm, called msmsEval, is implemented in C++
and can be compiled for Windows, Linux or MacOS X
using a standard GNU C++ compiler. msmsEval currently
accepts files in mzXML file format [29] and outputs a file
containing a summary of all MS/MS scans with their
respective p(D|+) and identifiable distribution percentile
values. There are options to generate filtered spectra in
DTA format for convenient further analysis. On a Pentium
Xeon 3.4Ghz processor, a typical analysis of a dataset con-
taining 10,000 scans will take less than one minute. msm-
sEval is open-source and available for download at http:/
/proteomics.ucd.ie/msmseval. Documentation and a
tutorial with practical information on the usage of msm-
sEval are available at the website.
Abbreviations
MudPIT – multidimensional protein identification tech-
nology
COFRADIC – combined fractional diagonal chromatogra-
phy
LCn – multidimensional liquid chromatography
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Supplementary figure 1. Venn diagram showing the breakdown of suc-
cessful spectrum annotations for the UCD dataset by different strategies.




Appendices. Contains details referred to in the manuscript regarding, 1) 
denoising of training datasets with k-nearest neighbor procedure, 2) com-
parison of classification procedures and 3) feature selection for the dis-
crimination model.




Supplementary figure 2. Predicted distributions of identifiable and uni-
dentifiable for a sample from the UCD test dataset (A) and sample A1 
from the ISB dataset (B). The number of spectra is calculated with spectra 
placed in bins of 0.25 for the discriminant score. Spectra with fewer than 
five peaks are removed in line with the EM-algorithm. The solid line rep-
resents the actual distribution of spectra of the complete dataset and the 
dotted line represents the estimated distributions of identifiable and uni-
dentifiable spectra using the expectation-maximization algorithm.
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